nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—PTGS2—melanoma	0.368	0.529	CbGaD
Magnesium salicylate—ALB—melanoma	0.328	0.471	CbGaD
Magnesium salicylate—ALB—Vemurafenib—melanoma	0.138	1	CbGbCtD
Magnesium salicylate—Skin papilloma—Vemurafenib—melanoma	0.00764	0.0855	CcSEcCtD
Magnesium salicylate—Localized exfoliation—Bleomycin—melanoma	0.0056	0.0627	CcSEcCtD
Magnesium salicylate—Ketoprofen—CXCR1—melanoma	0.00192	0.232	CrCbGaD
Magnesium salicylate—Burning sensation—Carmustine—melanoma	0.0019	0.0212	CcSEcCtD
Magnesium salicylate—PTGS2—leg—melanoma	0.00187	0.158	CbGeAlD
Magnesium salicylate—Stupor—Carmustine—melanoma	0.00176	0.0197	CcSEcCtD
Magnesium salicylate—Duodenal ulcer—Docetaxel—melanoma	0.00175	0.0196	CcSEcCtD
Magnesium salicylate—Olsalazine—IFNG—melanoma	0.00171	0.207	CrCbGaD
Magnesium salicylate—PTGS2—hindlimb—melanoma	0.00167	0.141	CbGeAlD
Magnesium salicylate—Hypocalcaemia—Dactinomycin—melanoma	0.00154	0.0172	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Bleomycin—melanoma	0.00144	0.0161	CcSEcCtD
Magnesium salicylate—PTGS2—appendage—melanoma	0.00143	0.121	CbGeAlD
Magnesium salicylate—Hearing impaired—Temozolomide—melanoma	0.00134	0.015	CcSEcCtD
Magnesium salicylate—Oesophagitis—Dactinomycin—melanoma	0.00129	0.0144	CcSEcCtD
Magnesium salicylate—Depressed level of consciousness—Carmustine—melanoma	0.00127	0.0142	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Carmustine—melanoma	0.00126	0.0141	CcSEcCtD
Magnesium salicylate—Heartburn—Docetaxel—melanoma	0.00123	0.0138	CcSEcCtD
Magnesium salicylate—Depressed level of consciousness—Temozolomide—melanoma	0.00123	0.0138	CcSEcCtD
Magnesium salicylate—Burning sensation—Docetaxel—melanoma	0.00122	0.0136	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Temozolomide—melanoma	0.00121	0.0136	CcSEcCtD
Magnesium salicylate—PTGS2—skin epidermis—melanoma	0.00119	0.101	CbGeAlD
Magnesium salicylate—Erythema multiforme—Vemurafenib—melanoma	0.00118	0.0132	CcSEcCtD
Magnesium salicylate—Erythema—Vemurafenib—melanoma	0.00109	0.0122	CcSEcCtD
Magnesium salicylate—Dysgeusia—Vemurafenib—melanoma	0.00107	0.0119	CcSEcCtD
Magnesium salicylate—Lethargy—Dactinomycin—melanoma	0.00104	0.0117	CcSEcCtD
Magnesium salicylate—Deafness—Temozolomide—melanoma	0.00103	0.0116	CcSEcCtD
Magnesium salicylate—PTGS1—endothelium—melanoma	0.000906	0.0765	CbGeAlD
Magnesium salicylate—Hearing impaired—Docetaxel—melanoma	0.000889	0.00995	CcSEcCtD
Magnesium salicylate—PTGS2—endothelium—melanoma	0.000866	0.0731	CbGeAlD
Magnesium salicylate—PTGS1—blood vessel—melanoma	0.000835	0.0706	CbGeAlD
Magnesium salicylate—Hypotension—Vemurafenib—melanoma	0.00083	0.00929	CcSEcCtD
Magnesium salicylate—Trisalicylate-choline—PTGS2—melanoma	0.00082	0.0992	CrCbGaD
Magnesium salicylate—Skin exfoliation—Docetaxel—melanoma	0.000808	0.00905	CcSEcCtD
Magnesium salicylate—Olsalazine—PPARG—melanoma	0.000806	0.0976	CrCbGaD
Magnesium salicylate—PTGS2—blood vessel—melanoma	0.000798	0.0675	CbGeAlD
Magnesium salicylate—Oesophagitis—Docetaxel—melanoma	0.000773	0.00866	CcSEcCtD
Magnesium salicylate—Decreased appetite—Vemurafenib—melanoma	0.000772	0.00865	CcSEcCtD
Magnesium salicylate—Constipation—Vemurafenib—melanoma	0.00076	0.00851	CcSEcCtD
Magnesium salicylate—Lightheadedness—Docetaxel—melanoma	0.000757	0.00848	CcSEcCtD
Magnesium salicylate—Weight increased—Temozolomide—melanoma	0.000727	0.00814	CcSEcCtD
Magnesium salicylate—Hepatitis—Dactinomycin—melanoma	0.000706	0.00791	CcSEcCtD
Magnesium salicylate—Flushing—Bleomycin—melanoma	0.000703	0.00787	CcSEcCtD
Magnesium salicylate—Deafness—Docetaxel—melanoma	0.000687	0.00769	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Dactinomycin—melanoma	0.000668	0.00748	CcSEcCtD
Magnesium salicylate—Erythema—Bleomycin—melanoma	0.000659	0.00738	CcSEcCtD
Magnesium salicylate—Hallucination—Carmustine—melanoma	0.000658	0.00737	CcSEcCtD
Magnesium salicylate—Flushing—Dactinomycin—melanoma	0.000656	0.00734	CcSEcCtD
Magnesium salicylate—Hepatitis—Temozolomide—melanoma	0.000639	0.00716	CcSEcCtD
Magnesium salicylate—Hallucination—Temozolomide—melanoma	0.000636	0.00712	CcSEcCtD
Magnesium salicylate—Pruritus—Vemurafenib—melanoma	0.000628	0.00704	CcSEcCtD
Magnesium salicylate—Lethargy—Docetaxel—melanoma	0.000627	0.00702	CcSEcCtD
Magnesium salicylate—Erythema—Dactinomycin—melanoma	0.000615	0.00689	CcSEcCtD
Magnesium salicylate—Flushing—Carmustine—melanoma	0.000614	0.00687	CcSEcCtD
Magnesium salicylate—Diarrhoea—Vemurafenib—melanoma	0.000608	0.00681	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Temozolomide—melanoma	0.000604	0.00677	CcSEcCtD
Magnesium salicylate—Tinnitus—Temozolomide—melanoma	0.000596	0.00667	CcSEcCtD
Magnesium salicylate—Flushing—Temozolomide—melanoma	0.000593	0.00664	CcSEcCtD
Magnesium salicylate—Dizziness—Vemurafenib—melanoma	0.000587	0.00658	CcSEcCtD
Magnesium salicylate—Erythema—Carmustine—melanoma	0.000576	0.00645	CcSEcCtD
Magnesium salicylate—Vomiting—Vemurafenib—melanoma	0.000565	0.00632	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Docetaxel—melanoma	0.000561	0.00628	CcSEcCtD
Magnesium salicylate—Rash—Vemurafenib—melanoma	0.00056	0.00627	CcSEcCtD
Magnesium salicylate—Dermatitis—Vemurafenib—melanoma	0.00056	0.00627	CcSEcCtD
Magnesium salicylate—Headache—Vemurafenib—melanoma	0.000556	0.00623	CcSEcCtD
Magnesium salicylate—Erythema—Temozolomide—melanoma	0.000556	0.00623	CcSEcCtD
Magnesium salicylate—Dysgeusia—Temozolomide—melanoma	0.000545	0.0061	CcSEcCtD
Magnesium salicylate—Confusional state—Bleomycin—melanoma	0.000543	0.00608	CcSEcCtD
Magnesium salicylate—Oedema—Bleomycin—melanoma	0.000538	0.00603	CcSEcCtD
Magnesium salicylate—Nausea—Vemurafenib—melanoma	0.000528	0.00591	CcSEcCtD
Magnesium salicylate—Anorexia—Bleomycin—melanoma	0.000513	0.00574	CcSEcCtD
Magnesium salicylate—Hypotension—Bleomycin—melanoma	0.000503	0.00563	CcSEcCtD
Magnesium salicylate—Oedema—Dactinomycin—melanoma	0.000502	0.00562	CcSEcCtD
Magnesium salicylate—Salicylate-sodium—PTGS2—melanoma	0.000497	0.0601	CrCbGaD
Magnesium salicylate—Ketoprofen—CXCL8—melanoma	0.000484	0.0586	CrCbGaD
Magnesium salicylate—Weight increased—Docetaxel—melanoma	0.000483	0.00541	CcSEcCtD
Magnesium salicylate—Anorexia—Dactinomycin—melanoma	0.000478	0.00536	CcSEcCtD
Magnesium salicylate—Confusional state—Carmustine—melanoma	0.000474	0.0053	CcSEcCtD
Magnesium salicylate—Oedema—Carmustine—melanoma	0.00047	0.00526	CcSEcCtD
Magnesium salicylate—Decreased appetite—Bleomycin—melanoma	0.000468	0.00524	CcSEcCtD
Magnesium salicylate—Pain—Bleomycin—melanoma	0.00046	0.00515	CcSEcCtD
Magnesium salicylate—Confusional state—Temozolomide—melanoma	0.000458	0.00513	CcSEcCtD
Magnesium salicylate—Oedema—Temozolomide—melanoma	0.000454	0.00508	CcSEcCtD
Magnesium salicylate—Anorexia—Carmustine—melanoma	0.000448	0.00501	CcSEcCtD
Magnesium salicylate—Epistaxis—Docetaxel—melanoma	0.000446	0.005	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Bleomycin—melanoma	0.000443	0.00497	CcSEcCtD
Magnesium salicylate—Hypotension—Carmustine—melanoma	0.000439	0.00492	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Temozolomide—melanoma	0.000439	0.00491	CcSEcCtD
Magnesium salicylate—Decreased appetite—Dactinomycin—melanoma	0.000436	0.00489	CcSEcCtD
Magnesium salicylate—Anorexia—Temozolomide—melanoma	0.000433	0.00485	CcSEcCtD
Magnesium salicylate—Pain—Dactinomycin—melanoma	0.000429	0.00481	CcSEcCtD
Magnesium salicylate—Urticaria—Bleomycin—melanoma	0.000428	0.00479	CcSEcCtD
Magnesium salicylate—Hepatitis—Docetaxel—melanoma	0.000425	0.00476	CcSEcCtD
Magnesium salicylate—Somnolence—Carmustine—melanoma	0.000418	0.00468	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Dactinomycin—melanoma	0.000414	0.00463	CcSEcCtD
Magnesium salicylate—Decreased appetite—Carmustine—melanoma	0.000408	0.00457	CcSEcCtD
Magnesium salicylate—Somnolence—Temozolomide—melanoma	0.000404	0.00452	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Docetaxel—melanoma	0.000402	0.0045	CcSEcCtD
Magnesium salicylate—Pain—Carmustine—melanoma	0.000402	0.0045	CcSEcCtD
Magnesium salicylate—Constipation—Carmustine—melanoma	0.000402	0.0045	CcSEcCtD
Magnesium salicylate—Dyspepsia—Temozolomide—melanoma	0.0004	0.00447	CcSEcCtD
Magnesium salicylate—Decreased appetite—Temozolomide—melanoma	0.000395	0.00442	CcSEcCtD
Magnesium salicylate—Flushing—Docetaxel—melanoma	0.000394	0.00442	CcSEcCtD
Magnesium salicylate—Pain—Temozolomide—melanoma	0.000388	0.00435	CcSEcCtD
Magnesium salicylate—Constipation—Temozolomide—melanoma	0.000388	0.00435	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Carmustine—melanoma	0.000387	0.00434	CcSEcCtD
Magnesium salicylate—PTGS1—skin of body—melanoma	0.000387	0.0327	CbGeAlD
Magnesium salicylate—Pruritus—Bleomycin—melanoma	0.000381	0.00426	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Temozolomide—melanoma	0.000374	0.00419	CcSEcCtD
Magnesium salicylate—Erythema—Docetaxel—melanoma	0.00037	0.00414	CcSEcCtD
Magnesium salicylate—PTGS2—skin of body—melanoma	0.00037	0.0312	CbGeAlD
Magnesium salicylate—Dysgeusia—Docetaxel—melanoma	0.000362	0.00406	CcSEcCtD
Magnesium salicylate—Urticaria—Temozolomide—melanoma	0.000361	0.00404	CcSEcCtD
Magnesium salicylate—PTGS1—mammalian vulva—melanoma	0.000353	0.0298	CbGeAlD
Magnesium salicylate—Nepafenac—PTGS2—melanoma	0.000348	0.0421	CrCbGaD
Magnesium salicylate—Diarrhoea—Dactinomycin—melanoma	0.000343	0.00385	CcSEcCtD
Magnesium salicylate—Vomiting—Bleomycin—melanoma	0.000342	0.00383	CcSEcCtD
Magnesium salicylate—Olsalazine—PTGS2—melanoma	0.00034	0.0412	CrCbGaD
Magnesium salicylate—Rash—Bleomycin—melanoma	0.000339	0.0038	CcSEcCtD
Magnesium salicylate—Dermatitis—Bleomycin—melanoma	0.000339	0.0038	CcSEcCtD
Magnesium salicylate—Diarrhoea—Carmustine—melanoma	0.000321	0.0036	CcSEcCtD
Magnesium salicylate—Pruritus—Temozolomide—melanoma	0.000321	0.0036	CcSEcCtD
Magnesium salicylate—Nausea—Bleomycin—melanoma	0.00032	0.00358	CcSEcCtD
Magnesium salicylate—Vomiting—Dactinomycin—melanoma	0.000319	0.00357	CcSEcCtD
Magnesium salicylate—Rash—Dactinomycin—melanoma	0.000316	0.00354	CcSEcCtD
Magnesium salicylate—Dizziness—Carmustine—melanoma	0.000311	0.00348	CcSEcCtD
Magnesium salicylate—Diarrhoea—Temozolomide—melanoma	0.000311	0.00348	CcSEcCtD
Magnesium salicylate—ALB—lymph node—melanoma	0.00031	0.0262	CbGeAlD
Magnesium salicylate—Confusional state—Docetaxel—melanoma	0.000304	0.00341	CcSEcCtD
Magnesium salicylate—Oedema—Docetaxel—melanoma	0.000302	0.00338	CcSEcCtD
Magnesium salicylate—Dizziness—Temozolomide—melanoma	0.0003	0.00336	CcSEcCtD
Magnesium salicylate—Vomiting—Carmustine—melanoma	0.000299	0.00334	CcSEcCtD
Magnesium salicylate—Nausea—Dactinomycin—melanoma	0.000298	0.00334	CcSEcCtD
Magnesium salicylate—Shock—Docetaxel—melanoma	0.000297	0.00333	CcSEcCtD
Magnesium salicylate—Rash—Carmustine—melanoma	0.000296	0.00332	CcSEcCtD
Magnesium salicylate—Dermatitis—Carmustine—melanoma	0.000296	0.00331	CcSEcCtD
Magnesium salicylate—Headache—Carmustine—melanoma	0.000294	0.0033	CcSEcCtD
Magnesium salicylate—Salsalate—PTGS2—melanoma	0.000289	0.035	CrCbGaD
Magnesium salicylate—Vomiting—Temozolomide—melanoma	0.000289	0.00323	CcSEcCtD
Magnesium salicylate—Anorexia—Docetaxel—melanoma	0.000288	0.00322	CcSEcCtD
Magnesium salicylate—Rash—Temozolomide—melanoma	0.000286	0.00321	CcSEcCtD
Magnesium salicylate—Dermatitis—Temozolomide—melanoma	0.000286	0.0032	CcSEcCtD
Magnesium salicylate—Headache—Temozolomide—melanoma	0.000284	0.00318	CcSEcCtD
Magnesium salicylate—Hypotension—Docetaxel—melanoma	0.000282	0.00316	CcSEcCtD
Magnesium salicylate—Nausea—Carmustine—melanoma	0.000279	0.00312	CcSEcCtD
Magnesium salicylate—Nausea—Temozolomide—melanoma	0.00027	0.00302	CcSEcCtD
Magnesium salicylate—Somnolence—Docetaxel—melanoma	0.000268	0.00301	CcSEcCtD
Magnesium salicylate—Dyspepsia—Docetaxel—melanoma	0.000266	0.00298	CcSEcCtD
Magnesium salicylate—Decreased appetite—Docetaxel—melanoma	0.000262	0.00294	CcSEcCtD
Magnesium salicylate—Pain—Docetaxel—melanoma	0.000258	0.00289	CcSEcCtD
Magnesium salicylate—Constipation—Docetaxel—melanoma	0.000258	0.00289	CcSEcCtD
Magnesium salicylate—PTGS1—head—melanoma	0.000252	0.0213	CbGeAlD
Magnesium salicylate—Feeling abnormal—Docetaxel—melanoma	0.000249	0.00279	CcSEcCtD
Magnesium salicylate—PTGS2—head—melanoma	0.000241	0.0204	CbGeAlD
Magnesium salicylate—Pruritus—Docetaxel—melanoma	0.000214	0.00239	CcSEcCtD
Magnesium salicylate—Diarrhoea—Docetaxel—melanoma	0.000207	0.00231	CcSEcCtD
Magnesium salicylate—Dizziness—Docetaxel—melanoma	0.0002	0.00224	CcSEcCtD
Magnesium salicylate—Vomiting—Docetaxel—melanoma	0.000192	0.00215	CcSEcCtD
Magnesium salicylate—Rash—Docetaxel—melanoma	0.00019	0.00213	CcSEcCtD
Magnesium salicylate—Dermatitis—Docetaxel—melanoma	0.00019	0.00213	CcSEcCtD
Magnesium salicylate—Headache—Docetaxel—melanoma	0.000189	0.00212	CcSEcCtD
Magnesium salicylate—Nausea—Docetaxel—melanoma	0.000179	0.00201	CcSEcCtD
Magnesium salicylate—Oxcarbazepine—ALB—melanoma	0.000179	0.0216	CrCbGaD
Magnesium salicylate—Salicylic acid—PTGS2—melanoma	0.000178	0.0215	CrCbGaD
Magnesium salicylate—PTGS1—lymph node—melanoma	0.000177	0.0149	CbGeAlD
Magnesium salicylate—PTGS2—lymph node—melanoma	0.000169	0.0143	CbGeAlD
Magnesium salicylate—Salicylic acid—ALB—melanoma	0.000159	0.0192	CrCbGaD
Magnesium salicylate—Salicylic acid—ABCB1—melanoma	0.000151	0.0183	CrCbGaD
Magnesium salicylate—Ketoprofen—PTGS2—melanoma	0.000141	0.0171	CrCbGaD
Magnesium salicylate—Ketoprofen—ALB—melanoma	0.000126	0.0152	CrCbGaD
Magnesium salicylate—Carbamazepine—ABCB1—melanoma	0.000116	0.0141	CrCbGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—FASN—melanoma	4.49e-05	0.000799	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—TNF—melanoma	4.49e-05	0.000797	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—IL6—melanoma	4.47e-05	0.000795	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—SPARC—melanoma	4.46e-05	0.000793	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—F2R—melanoma	4.46e-05	0.000793	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—LUM—melanoma	4.46e-05	0.000792	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TNF—melanoma	4.38e-05	0.000779	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—FN1—melanoma	4.38e-05	0.000778	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—SDHD—melanoma	4.37e-05	0.000777	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—BSG—melanoma	4.37e-05	0.000777	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CSPG4—melanoma	4.37e-05	0.000777	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HPSE—melanoma	4.37e-05	0.000777	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SLC6A11—melanoma	4.31e-05	0.000765	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIP4K2A—melanoma	4.31e-05	0.000765	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CUBN—melanoma	4.29e-05	0.000762	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GPAM—melanoma	4.23e-05	0.000752	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CG—melanoma	4.19e-05	0.000744	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—MTAP—melanoma	4.19e-05	0.000744	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	4.18e-05	0.000743	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—HSPA5—melanoma	4.18e-05	0.000742	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CSPG4—melanoma	4.14e-05	0.000736	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—EGF—melanoma	4.14e-05	0.000736	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	4.1e-05	0.000729	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	4.09e-05	0.000727	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—GNA11—melanoma	4.08e-05	0.000725	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—GAB2—melanoma	4.08e-05	0.000725	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—RPS3—melanoma	4.08e-05	0.000724	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SKI—melanoma	4.01e-05	0.000713	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	3.99e-05	0.000709	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	3.95e-05	0.000702	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	3.93e-05	0.000699	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TP53—melanoma	3.87e-05	0.000687	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	3.86e-05	0.000686	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	3.85e-05	0.000685	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—HDAC2—melanoma	3.84e-05	0.000682	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—IGF1—melanoma	3.84e-05	0.000682	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	3.83e-05	0.000681	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—GNAQ—melanoma	3.79e-05	0.000674	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—ITGA4—melanoma	3.79e-05	0.000674	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—CD44—melanoma	3.79e-05	0.000674	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IFNB1—melanoma	3.77e-05	0.000669	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PHGDH—melanoma	3.73e-05	0.000663	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—LUM—melanoma	3.73e-05	0.000663	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PLCB4—melanoma	3.7e-05	0.000658	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CD—melanoma	3.68e-05	0.000654	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IFNA1—melanoma	3.67e-05	0.000653	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—HPSE—melanoma	3.66e-05	0.00065	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—FASN—melanoma	3.64e-05	0.000646	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—IL6—melanoma	3.62e-05	0.000643	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PLA2G6—melanoma	3.6e-05	0.00064	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CUBN—melanoma	3.59e-05	0.000638	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—SYK—melanoma	3.57e-05	0.000634	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—IL6—melanoma	3.54e-05	0.000629	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—ITGAV—melanoma	3.5e-05	0.000622	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—AKT3—melanoma	3.5e-05	0.000622	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SLC6A11—melanoma	3.48e-05	0.000619	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIP4K2A—melanoma	3.48e-05	0.000619	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	3.48e-05	0.000618	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SDHD—melanoma	3.47e-05	0.000617	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—BSG—melanoma	3.47e-05	0.000617	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CSPG4—melanoma	3.47e-05	0.000617	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IFNA2—melanoma	3.42e-05	0.000608	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC5A5—melanoma	3.4e-05	0.000604	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—MTAP—melanoma	3.39e-05	0.000602	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GPAM—melanoma	3.36e-05	0.000597	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HDAC6—melanoma	3.31e-05	0.000589	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.31e-05	0.000588	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	3.29e-05	0.000585	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—VCAN—melanoma	3.23e-05	0.000575	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CB—melanoma	3.21e-05	0.00057	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—melanoma	3.2e-05	0.000569	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—ITGB1—melanoma	3.18e-05	0.000565	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NPPA—melanoma	3.14e-05	0.000558	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	3.13e-05	0.000557	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	3.13e-05	0.000556	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—VCAN—melanoma	3.07e-05	0.000545	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.06e-05	0.000544	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—WNT5A—melanoma	3.04e-05	0.00054	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PHGDH—melanoma	3.02e-05	0.000537	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—LUM—melanoma	3.02e-05	0.000537	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—melanoma	2.98e-05	0.00053	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—HPSE—melanoma	2.96e-05	0.000526	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	2.96e-05	0.000526	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.95e-05	0.000525	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—IL2—melanoma	2.95e-05	0.000524	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—HGF—melanoma	2.91e-05	0.000517	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CUBN—melanoma	2.91e-05	0.000517	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—CSF2—melanoma	2.88e-05	0.000511	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PLA2G6—melanoma	2.86e-05	0.000508	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SDHD—melanoma	2.81e-05	0.000499	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CSPG4—melanoma	2.81e-05	0.000499	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—BSG—melanoma	2.81e-05	0.000499	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—ITGB3—melanoma	2.76e-05	0.00049	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PRKCA—melanoma	2.76e-05	0.00049	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP17A1—melanoma	2.73e-05	0.000485	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GPAM—melanoma	2.72e-05	0.000483	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	2.72e-05	0.000483	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.69e-05	0.000478	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	2.66e-05	0.000472	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.63e-05	0.000467	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	2.59e-05	0.000461	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GNA11—melanoma	2.58e-05	0.000458	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—VCAN—melanoma	2.57e-05	0.000456	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—RAC1—melanoma	2.56e-05	0.000454	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—FASN—melanoma	2.52e-05	0.000448	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	2.51e-05	0.000445	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—SLC5A5—melanoma	2.48e-05	0.000441	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—MMP1—melanoma	2.47e-05	0.000439	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—GAB2—melanoma	2.44e-05	0.000434	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.43e-05	0.000432	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—CDK2—melanoma	2.43e-05	0.000431	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GNAQ—melanoma	2.4e-05	0.000426	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CD44—melanoma	2.4e-05	0.000426	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FASN—melanoma	2.39e-05	0.000425	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	2.37e-05	0.000421	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.35e-05	0.000417	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.35e-05	0.000417	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.32e-05	0.000413	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PLA2G6—melanoma	2.31e-05	0.000411	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP1B1—melanoma	2.3e-05	0.000408	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FOXO4—melanoma	2.3e-05	0.000408	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HDAC2—melanoma	2.3e-05	0.000408	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CXCR4—melanoma	2.3e-05	0.000408	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CD44—melanoma	2.27e-05	0.000403	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—FN1—melanoma	2.26e-05	0.000401	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	2.26e-05	0.000401	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—NOS2—melanoma	2.23e-05	0.000396	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.22e-05	0.000395	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP17A1—melanoma	2.17e-05	0.000385	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CG—melanoma	2.16e-05	0.000384	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.14e-05	0.00038	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—EGF—melanoma	2.13e-05	0.000379	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.11e-05	0.000375	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—AKT3—melanoma	2.1e-05	0.000372	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—VCAN—melanoma	2.08e-05	0.000369	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GNA11—melanoma	2.05e-05	0.000363	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.03e-05	0.00036	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—FASN—melanoma	2e-05	0.000356	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IGF1—melanoma	1.98e-05	0.000351	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SLC5A5—melanoma	1.97e-05	0.00035	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.97e-05	0.000349	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	1.96e-05	0.000348	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GNAQ—melanoma	1.9e-05	0.000338	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CD44—melanoma	1.9e-05	0.000338	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CD—melanoma	1.9e-05	0.000337	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.9e-05	0.000337	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ABCB1—melanoma	1.89e-05	0.000336	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.86e-05	0.000331	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ERBB4—melanoma	1.85e-05	0.000329	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDKN2B—melanoma	1.83e-05	0.000326	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP1B1—melanoma	1.82e-05	0.000324	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CD86—melanoma	1.77e-05	0.000315	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP17A1—melanoma	1.75e-05	0.000311	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PRKCA—melanoma	1.74e-05	0.000309	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.73e-05	0.000307	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ERCC2—melanoma	1.73e-05	0.000307	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FGF1—melanoma	1.72e-05	0.000306	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PDGFRA—melanoma	1.67e-05	0.000296	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GNA11—melanoma	1.65e-05	0.000294	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CB—melanoma	1.65e-05	0.000294	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PRKCA—melanoma	1.65e-05	0.000293	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ERCC2—melanoma	1.64e-05	0.000291	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—FASN—melanoma	1.62e-05	0.000288	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MAP2K2—melanoma	1.61e-05	0.000287	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.61e-05	0.000286	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	1.6e-05	0.000284	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SLC5A5—melanoma	1.59e-05	0.000283	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GNAQ—melanoma	1.54e-05	0.000273	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CD44—melanoma	1.54e-05	0.000273	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TERT—melanoma	1.53e-05	0.000273	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HLA-A—melanoma	1.53e-05	0.000273	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—RAC1—melanoma	1.53e-05	0.000272	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IL2—melanoma	1.52e-05	0.00027	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.51e-05	0.000268	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ABCB1—melanoma	1.5e-05	0.000267	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.49e-05	0.000265	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP1B1—melanoma	1.47e-05	0.000262	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HIF1A—melanoma	1.47e-05	0.000261	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.43e-05	0.000254	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PRKCA—melanoma	1.38e-05	0.000245	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ERCC2—melanoma	1.37e-05	0.000243	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CG—melanoma	1.36e-05	0.000242	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NOS2—melanoma	1.33e-05	0.000237	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NOTCH1—melanoma	1.32e-05	0.000235	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PPARG—melanoma	1.32e-05	0.000234	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.3e-05	0.000231	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CD80—melanoma	1.29e-05	0.00023	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—APC—melanoma	1.29e-05	0.00023	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—KIT—melanoma	1.29e-05	0.00023	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—VEGFA—melanoma	1.29e-05	0.000229	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—EGF—melanoma	1.28e-05	0.000227	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—NRAS—melanoma	1.28e-05	0.000227	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—MAPK3—melanoma	1.22e-05	0.000217	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—BRAF—melanoma	1.21e-05	0.000216	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ABCB1—melanoma	1.21e-05	0.000216	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CD—melanoma	1.2e-05	0.000213	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ALB—melanoma	1.18e-05	0.00021	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—MAPK1—melanoma	1.16e-05	0.000207	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MAP2K1—melanoma	1.14e-05	0.000203	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CD—melanoma	1.14e-05	0.000202	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.13e-05	0.000202	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PRKCA—melanoma	1.12e-05	0.000199	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ERCC2—melanoma	1.11e-05	0.000197	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—KRAS—melanoma	1.1e-05	0.000195	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FGF2—melanoma	1.09e-05	0.000193	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CG—melanoma	1.08e-05	0.000192	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CB—melanoma	1.04e-05	0.000186	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PPARG—melanoma	1.04e-05	0.000186	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PTGS2—melanoma	1.03e-05	0.000184	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MDM2—melanoma	1.02e-05	0.000181	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CA—melanoma	1.01e-05	0.000179	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ERBB2—melanoma	1e-05	0.000178	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CB—melanoma	9.9e-06	0.000176	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CD4—melanoma	9.88e-06	0.000176	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TP53—melanoma	9.76e-06	0.000173	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CD—melanoma	9.51e-06	0.000169	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ALB—melanoma	9.39e-06	0.000167	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—HRAS—melanoma	9.33e-06	0.000166	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDKN1B—melanoma	9.29e-06	0.000165	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.18e-06	0.000163	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PTEN—melanoma	9.03e-06	0.00016	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CTNNB1—melanoma	8.78e-06	0.000156	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CG—melanoma	8.75e-06	0.000156	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CDKN1A—melanoma	8.57e-06	0.000152	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PTEN—melanoma	8.56e-06	0.000152	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PPARG—melanoma	8.45e-06	0.00015	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CB—melanoma	8.29e-06	0.000147	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—AKT1—melanoma	8.24e-06	0.000146	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CD—melanoma	7.7e-06	0.000137	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—STAT3—melanoma	7.65e-06	0.000136	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NRAS—melanoma	7.63e-06	0.000136	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MAPK3—melanoma	7.31e-06	0.00013	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PTEN—melanoma	7.17e-06	0.000127	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MYC—melanoma	7.11e-06	0.000126	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MAPK1—melanoma	6.96e-06	0.000124	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—EGFR—melanoma	6.95e-06	0.000124	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CB—melanoma	6.71e-06	0.000119	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTGS2—melanoma	6.65e-06	0.000118	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—KRAS—melanoma	6.57e-06	0.000117	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CA—melanoma	6.37e-06	0.000113	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CA—melanoma	6.04e-06	0.000107	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTEN—melanoma	5.8e-06	0.000103	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HRAS—melanoma	5.58e-06	9.92e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—IL6—melanoma	5.34e-06	9.5e-05	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—AKT1—melanoma	5.2e-06	9.24e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CA—melanoma	5.05e-06	8.98e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—AKT1—melanoma	4.93e-06	8.76e-05	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—AKT1—melanoma	4.13e-06	7.34e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CA—melanoma	4.09e-06	7.27e-05	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—AKT1—melanoma	3.34e-06	5.94e-05	CbGpPWpGaD
